Literature DB >> 6155612

Influence of preimmunization antibody levels on the specificity of the immune response to related polysaccharide antigens.

C J Baker, D L Kasper, M S Edwards, G Schiffman.   

Abstract

We studied the influence of preimmunization antibody level on the immune response of adults to one of two structurally related yet immunologically distinct type-specific polysaccharides from Type III Group B streptococcus and Type 14 pneumonococcus. Four weeks after immunization with multivalent pneumococcal vaccine, 20 subjects with low levels of antibody to Type III Group B streptococcus antigen had no significant increase in antibody to this antigen (P greater than 0.05), but all volunteers with moderate to high preimmunization antibody levels who were immunized with Pneumovax had significant increases (P less than 0.01). However, the streptococcal antibody response to pneumococcal Type 14 antigen was weaker and briefer than that in 10 adults given Type III Group B streptococcus vaccine(P less than 0.05). Preimmunization antibody levels influenced the immune response to a structurally similar polysaccharide antigen, but specific Type III polysaccharide antigen appeared necessary to induce a primary antibody response in "nonimmune" adults. We conclude that immunization of mothers with pneumococcal vaccine is not likely to prevent neonatal Type III Group B streptococcal infection, despite immunologic similarities between the two organisms.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6155612     DOI: 10.1056/NEJM198007243030401

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  15 in total

1.  Measurement of human antibodies to type III group B Streptococcus.

Authors:  D L Kasper; M R Wessels; H K Guttormsen; L C Paoletti; M S Edwards; C J Baker
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

Review 2.  Pneumonias in newborn babies.

Authors:  M Singh; A K Deorari
Journal:  Indian J Pediatr       Date:  1995 May-Jun       Impact factor: 1.967

3.  A peptide mimotope of type 8 pneumococcal capsular polysaccharide induces a protective immune response in mice.

Authors:  Ulrike K Buchwald; Andrew Lees; Michael Steinitz; Liise-Anne Pirofski
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

4.  Capsular polysaccharide regulates neutrophil complement receptor interactions with type III group B streptococci.

Authors:  M S Edwards; M R Wessels; C J Baker
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

5.  Immune-mediated diseases and immunodeficiencies associated with thymic epithelial neoplasms.

Authors:  Muhammad Rizwan Khawaja; Robert P Nelson; Nicholas Miller; Sunil S Badve; Elizabeth Loehrer; Magdalena Czader; Susan M Perkins; Kenneth Kesler; Patrick J Loehrer
Journal:  J Clin Immunol       Date:  2012-01-08       Impact factor: 8.317

6.  Mouse protection assay for group B streptococcus type III.

Authors:  D O Fleming
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

7.  Immunochemical analysis and immunogenicity of the type II group B streptococcal capsular polysaccharide.

Authors:  D L Kasper; C J Baker; B Galdes; E Katzenellenbogen; H J Jennings
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

Review 8.  Capsular polysaccharide vaccines today.

Authors:  P H Mäkelä
Journal:  Infection       Date:  1984       Impact factor: 3.553

9.  Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes.

Authors:  L C Madoff; L C Paoletti; J Y Tai; D L Kasper
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

10.  Type I Streptococcus pneumoniae carbohydrate utilizes a nitric oxide and MHC II-dependent pathway for antigen presentation.

Authors:  Christopher D Velez; Colleen J Lewis; Dennis L Kasper; Brian A Cobb
Journal:  Immunology       Date:  2009-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.